Skip to content

Clinical trials

Terminated Phase 1/2 Anemia, Refractory, with Excess of Blasts trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Phase 1/2 Status: Terminated Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20141
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center1
IGF Oncology, LLC1
Incyte Corporation1
Masonic Cancer Center, University of Minnesota1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts5
Blast Crisis3
Leukemia, Myeloid, Acute3
Myelodysplastic Syndromes3
Burkitt Lymphoma2
Leukemia2
Lymphoma2
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Large-Cell, Immunoblastic2

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.